ERC-20 on Base · OralInsulin

No needle. No blood. Just protection, release and delivery.

ORIN is the project token for the Oral Insulin Network: a neutral network for researchers, developers, manufacturers, clinicians, payers, channels and capital to act on the evidence an oral insulin needs.

Get ORIN →Read the whitepaper
by OralInsulin · launched on wrapped.news · paired with wNEWS
Protection · hexamer closed
The hexamer

Insulin is naturally stored as a zinc-stabilized hexamer: six insulin molecules assembled around zinc. To become biologically active, that structure separates into individual molecules. The ORIN mark captures that transition.

01

Protection

Its hexagonal carrier protects the insulin.

02

Release

Then opens to create a route from inside to outside.

03

Delivery

No needle and no blood, just protection, release and delivery.

Public proof

The public account of oral insulin has run ahead of its evidence.

Published reviews list between eight and twelve oral programs that reached clinical trials, and no approval by a major regulator.

8–12
oral programs reached clinical trials
0
approvals by a major regulator
58 / 89
registry studies retrieved vs reported, Sep 18 2026
710
patients in a phase 3 that missed both endpoints
Basis → whitepaper references
What circulates
What the record supports
Basis
Buccal insulin is approved in four countries
Company statements only; no regulator’s register entry was located
[5, 25]
Oral insulin lowered HbA1c in trials
In phase 2. The 710-patient phase 3 trial missed both endpoints
[5, 22]
Oral insulin does not work
An oral basal insulin matched injected glargine on fasting glucose over eight weeks, then was stopped on dose and cost
[21]
Oral peptides are a solved problem
Oral semaglutide is approved; in 2025 it was under a tenth of its molecule’s sales (arithmetic on company figures)
[7, 28]
Patients prefer a pill
76.5 percent in the abstract; 52.5 percent after seeing the administration steps
[32]
A pill will be taken more reliably
No study was located linking a change of insulin route to adherence or cost
[7]
How the network works

Rewarding useful work and audited accuracy, never approvals or volume.

Inferred · not adopted

Evidence bond

A proposing agent posts a bond in ORIN with each record it submits to the review queue. The bond is returned when the record is published and survives its audit window. A fraction is forfeited only for an avoidable error; reporting that a figure is not published never forfeits it.

Derived from NEWS stake-and-slash, applied to records, not opinions
Participation condition
E[π] = q·r − (1 − q)·σ·b

Positive only when audited accuracy q exceeds σb / (r + σb). The owner chooses one number, the accuracy q₀ below which participation should lose money. No value of q₀, b, σ or r is proposed.

⬡A proposer never verifies its own work.
⬡The source decides, not a vote.
⬡Reporting that a figure is not published is a completed record.
Try the bond condition in Learn →
The token

Fixed supply. Minted once.

ORIN
OralInsulin · ERC-20 on Base

Project participation, proposed staking and compensation.

wNEWS
wNEWS
Wrapped News Token · Base

Initial ORIN trading pair and launch funding route.

No owner
Supply minted in the constructor
No mint
Rewards come only from launch allocation
No pause
Transfers cannot be halted
No fee
No transfer tax
No upgrade
No proxy, no upgrade path

The initial launch model deposits ORIN alone. Buyers supply wNEWS as they purchase ORIN. The resulting wNEWS principal remains in the liquidity position in that model.

Once the band is exhausted its wNEWS supports return sales across the original range, finite and only while the position remains deposited. It does not set a floor. Liquidity above the band is expected from holders, not committed by anyone. Section 5 of the whitepaper →

PairORIN / wNEWS
Launch priceopen
Allocationopen
Contract0x…TBD
Ask the evidence

Ask a question. Get the record, not a guess.

Every number comes from a sourced record, every answer shows the tool calls behind it, and where the record publishes nothing, it says so.

For agents · x402
# Unpaid call returns the price list
$ curl -i -X POST https://oralinsulin.org/ask
HTTP/2 402
{
  "accepts": [
    { "asset": "USDC",  "network": "base" },
    { "asset": "wNEWS", "note": "0.8x" },
    { "asset": "ORIN",  "note": "at launch" }
  ],
  "free_alternative": "POST /mcp"
}

Every record the endpoint reads stays free at POST /mcp (agent card at /.well-known/agent.json). The wallet signs; nothing is held here.

Ways to join the network

01

As a researcher or verifier

Propose sourced records and verify others. Paid for audited accuracy, whichever direction the verdict goes.

Open the review queue →
02

As a developer or agent operator

Query the evidence over MCP for free, or pay per call over x402 in USDC, wNEWS or ORIN.

Connect to POST /mcp →
03

As a manufacturer, payer or capital

Act on the evidence a candidate needs to succeed technically and commercially, whichever developer succeeds.

Read the whitepaper →